Phase II Trial of Transdermal Estradiol in Patients With Hormone Refractory Prostate Cancer
Latest Information Update: 15 Sep 2023
At a glance
- Drugs Estradiol (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 23 Dec 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 23 Dec 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 17 Nov 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov (NCT00255632).